All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

Obtaining a meticulous occupational, environmental, and travel history is often the definitive step in diagnosing infectious diseases with nonspecific systemic presentations. Match each patient's unique historical profile and clinical presentation with the most likely etiologic diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The exposure profiles logically match with the corresponding endemic and zoonotic diseases: Abattoir worker to Brucellosis; Sheep lambing to Q fever; Bat guano bridge inspection to Histoplasmosis; Deer mice trapping to Hantavirus; and Sphagnum moss landscaping to Sporotrichosis.

Accurate diagnosis of zoonotic and environmental infections relies heavily on a thorough medical history, specifically detailed occupational and exposure inquiries. Each clinical profile contains classic epidemiological clues (e.g., deer mouse droppings for Hantavirus, placental tissue for Q fever, bat guano for Histoplasmosis) that, when combined with the specific clinical syndrome, definitively establish the diagnosis.

Step-by-Step Solution

Identify the key occupational and environmental exposures in each patient's history.

Exposures identified: livestock viscera/dairy, sheep lambing, bat guano, deer mice, and sphagnum moss.

Many zoonotic and environmental infections have overlapping systemic symptoms; the specific vector or reservoir exposure is the strongest diagnostic clue.

Correlate the specific exposure with known endemic diseases.

Matched exposures to Brucella, Coxiella, Histoplasma, Hantavirus, and Sporothrix, respectively.

Understanding the ecological niches of these pathogens narrows the differential diagnosis immediately.

Verify that the clinical presentation matches the pathophysiology of the suspected organism.

Clinical syndromes (sacroiliitis, transaminitis/pneumonia, palatal ulcers, pulmonary edema, nodular lymphangitis) perfectly align with the typical manifestations of the matched pathogens.

Ensures the final diagnosis is supported by both historical risk factors and objective clinical findings.

Key Concept

Zoonotic and Environmental Exposure History Evaluation

Estimated Time:2m 0s

Question 1522Question →

A 64-year-old man comes to the oncology clinic for a follow-up evaluation. Three months ago, he was diagnosed with metastatic cutaneous melanoma. Molecular profiling of the tumor tissue revealed a valine-to-glutamic acid substitution at codon 600 of the BRAF gene (BRAF V600E). He was subsequently started on targeted oral monotherapy with vemurafenib. Today, the patient reports the rapid appearance of several raised, crusted skin lesions on his extensor forearms and trunk over the last 3 weeks. Physical examination shows multiple $1 \text{ cm}$ to $2 \text{ cm}$ hyperkeratotic, dome-shaped nodules with central keratinous plugs. A shave biopsy of one of the lesions confirms well-differentiated squamous cell carcinoma. Which of the following cellular mechanisms best explains the development of this patient's new cutaneous neoplasms?

Direct alkylation of DNA leading to unrepairable strand breaks and escape from cell cycle arrest

Paradoxical dimerization and hyperactivation of RAF kinases in cells with wild-type BRAF

Pharmacologic suppression of cellular immunosurveillance permitting proliferation of latent oncogenic viruses

Inhibition of nucleotide excision repair enzymes leading to rapid accumulation of ultraviolet-induced mutations

Constitutive activation of epidermal growth factor receptors due to loss of negative feedback loops

Show answer & explanation

Answer: Paradoxical dimerization and hyperactivation of RAF kinases in cells with wild-type BRAF

Answer

Paradoxical dimerization and hyperactivation of RAF kinases in cells with wild-type BRAF

The correct answer accurately identifies that BRAF inhibitors (such as vemurafenib) block the mutant BRAF V600E kinase but, in normal cells with wild-type BRAF, they induce RAF dimerization. If these wild-type cells harbor an upstream RAS mutation (such as an HRAS mutation common in sun-damaged skin), the dimerization leads to paradoxical hyperactivation of the downstream MEK/ERK (MAPK) pathway. This intense proliferative signal drives the rapid formation of keratoacanthomas and cutaneous squamous cell carcinomas. To prevent this, BRAF inhibitors are now standardly co-administered with MEK inhibitors (e.g., trametinib), which block the pathway downstream of RAF.

Step-by-Step Solution

Identify the patient's primary disease and current treatment.

The patient has metastatic melanoma with a BRAF V600E mutation and is being treated with vemurafenib, a selective BRAF inhibitor.

Establishing the specific pharmacologic intervention is required to determine its unique adverse effect profile.

Characterize the new clinical finding based on history, physical examination, and biopsy results.

The patient has developed new eruptive skin nodules that are histologically confirmed to be well-differentiated squamous cell carcinomas (or keratoacanthomas).

Recognizing this specific secondary malignancy is key to diagnosing the drug-induced complication.

Link the adverse effect to the molecular mechanism of the targeted therapy.

Vemurafenib causes paradoxical activation of the mitogen-activated protein kinase (MAPK) pathway in cells that do not possess the BRAF V600E mutation.

Understanding the cellular and molecular consequences of targeted kinase inhibition is essential for managing oncologic toxicities.

Key Concept

BRAF inhibitors (e.g., vemurafenib, dabrafenib) can induce secondary cutaneous squamous cell carcinomas and keratoacanthomas through paradoxical activation of the RAF/MEK/ERK (MAPK) signaling pathway in wild-type BRAF cells, often driven by upstream HRAS mutations.

Question 1523Question →

A 54-year-old man presents to the otolaryngology clinic with a painless right-sided neck mass that he first noticed 2 months ago. He reports no dysphagia, hoarseness, weight loss, or night sweats. He is a lifelong non-smoker and consumes alcohol on rare occasions. His past medical history is unremarkable, and he takes no daily medications. Physical examination reveals a 3.5-cm, firm, mobile, non-tender lymph node in the right jugulodigastric region. Flexible laryngoscopy shows a small, irregular exophytic lesion on the right palatine tonsil. Biopsy of the tonsillar lesion confirms non-keratinizing squamous cell carcinoma. Subsequent immunohistochemical staining of the tumor tissue demonstrates strong, diffuse positivity for the p16 protein. Which of the following cellular mechanisms is most directly responsible for the immunohistochemical findings in this patient's neoplasm?

Viral oncoprotein-mediated degradation of a cell cycle regulator leading to compensatory upregulation of a cyclin-dependent kinase inhibitor

Viral oncoprotein-mediated ubiquitination of a key tumor suppressor preventing normal apoptotic responses to DNA damage

Epigenetic hypermethylation of a tumor suppressor gene promoter resulting in the loss of G1/S phase cell cycle arrest

Somatic point mutation in a proto-oncogene causing constitutive activation of a receptor tyrosine kinase

Chromosomal translocation creating a fusion gene that functions as a chimeric transcription factor

Show answer & explanation

Answer: Viral oncoprotein-mediated degradation of a cell cycle regulator leading to compensatory upregulation of a cyclin-dependent kinase inhibitor

Answer

Viral oncoprotein-mediated degradation of a cell cycle regulator leading to compensatory upregulation of a cyclin-dependent kinase inhibitor

The patient has an HPV-associated oropharyngeal squamous cell carcinoma, which typically presents in younger, non-smoking patients with neck masses and primary lesions in the tonsils or base of the tongue. High-risk HPV strains express the E7 oncoprotein, which binds and degrades the retinoblastoma (Rb) tumor suppressor protein (a cell cycle regulator). The functional loss of Rb releases the E2F transcription factor, promoting unregulated cellular progression from the G1 to the S phase. Normally, Rb exerts negative feedback on the production of p16, which is a cyclin-dependent kinase inhibitor (CDKN2A). When Rb is degraded by E7, this negative feedback is lost, leading to massive, compensatory cellular overproduction of p16 in a futile attempt to halt the cell cycle. Therefore, diffuse p16 positivity on immunohistochemistry serves as a strong surrogate marker for an HPV-driven neoplastic process.

Step-by-Step Solution

Analyze the clinical presentation and diagnostic findings.

The patient has oropharyngeal (tonsillar) squamous cell carcinoma. He is a non-smoker, and the tumor is strongly positive for p16.

Identifying the patient demographic and the specific immunohistochemical marker is necessary to determine the underlying etiology of the head and neck cancer.

Correlate the diagnostic findings with the specific neoplastic etiology.

p16 positivity in an oropharyngeal mass in a non-smoker is a highly sensitive and specific surrogate marker for infection with high-risk Human Papillomavirus (HPV), typically strains 16 or 18.

HPV-associated squamous cell carcinomas have distinct molecular profiles, prognoses, and pathophysiologic mechanisms compared to traditional smoking/alcohol-associated carcinomas.

Trace the foundational molecular mechanism of the identified etiology to the laboratory finding.

HPV produces the E7 oncoprotein, which binds and degrades the retinoblastoma (Rb) protein. The loss of Rb frees the E2F transcription factor. Because Rb normally suppresses p16 production via negative feedback, the loss of Rb leads to uninhibited, massive compensatory overexpression of the p16 protein.

The question asks for the direct cellular mechanism responsible for the specific immunohistochemical finding (p16 overexpression).

Key Concept

Molecular pathogenesis of HPV-associated squamous cell carcinoma and the basis for p16 overexpression.

Estimated Time:1m 30s

Question 1524Question →

A 38-year-old woman is brought to the emergency department by her husband due to profound confusion, intractable nausea, and severe weakness. Two weeks ago, she visited her primary care physician complaining of a 1-year history of fatigue, a 5-kg (11-lb) weight loss, cold intolerance, and amenorrhea following a complicated vaginal delivery that required massive blood transfusion. Laboratory testing at that time showed a thyroid-stimulating hormone (TSH) level of 0.4 mIU/L (reference: 0.5–5.0 mIU/L) and a free thyroxine (T4) level of 0.3 ng/dL (reference: 0.9–1.7 ng/dL). She was diagnosed with hypothyroidism and started on levothyroxine. On arrival at the ED today, her temperature is 36.1°C (97.0°F), blood pressure is 78/46 mm Hg, pulse is 112/min, and respiratory rate is 18/min. Physical examination reveals delayed deep tendon reflexes and generalized weakness, but no hyperpigmentation. Laboratory results show:

Laboratory Parameter	Result	Reference Range
Sodium	128 mEq/L	136–145 mEq/L
Potassium	4.8 mEq/L	3.5–5.0 mEq/L
Glucose	52 mg/dL	70–100 mg/dL

Which of the following cellular or biochemical mechanisms best explains the pathogenesis of this patient's acute presentation?

Thyroid hormone-mediated enhancement of hepatic glucocorticoid clearance

Direct competitive inhibition of pituitary adrenocorticotropic hormone synthesis by exogenous thyroxine

Acute ischemic necrosis of the anterior pituitary gland due to increased metabolic demand

Exacerbation of preexisting peripheral vasodilation caused by thyroid hormone action on vascular smooth muscle

Autoimmune destruction of the adrenal cortex mediated by cross-reactive thyroid peroxidase antibodies

Show answer & explanation

Answer: Thyroid hormone-mediated enhancement of hepatic glucocorticoid clearance

Answer

Thyroid hormone-mediated enhancement of hepatic glucocorticoid clearance

The correct answer identifies the mechanism of thyroid hormone-mediated enhancement of hepatic glucocorticoid clearance. This patient developed Sheehan syndrome (ischemic necrosis of the anterior pituitary) following a complicated delivery with massive blood transfusion, leading to panhypopituitarism (central hypothyroidism, secondary hypogonadism, and central adrenal insufficiency). When levothyroxine was initiated to treat the hypothyroidism, it increased her basal metabolic rate and upregulated hepatic enzymes (such as 11-beta-hydroxysteroid dehydrogenase), accelerating the metabolism and clearance of her already diminished cortisol pool. This abrupt depletion of cortisol precipitated an acute adrenal crisis, characterized by hypotension, hypoglycemia, and hyponatremia. For this reason, glucocorticoid replacement must always precede thyroid hormone replacement in patients with suspected panhypopituitarism.

Step-by-Step Solution

Analyze the patient's history and initial laboratory findings.

The patient has a history of postpartum hemorrhage followed by amenorrhea, fatigue, and low TSH with low free T4. This constellation is diagnostic of Sheehan syndrome (postpartum ischemic necrosis of the anterior pituitary).

Identifying the underlying condition is necessary to understand the full scope of her endocrine deficiencies, which include central hypothyroidism, secondary hypogonadism, and central adrenal insufficiency.

Evaluate the current acute presentation in the emergency department.

She presents with distributive shock (hypotension, tachycardia), hypoglycemia, and hyponatremia shortly after starting levothyroxine.

These findings are the classic triad of an acute adrenal crisis, necessitating an understanding of the precipitating event.

Connect the initiation of levothyroxine to the precipitation of adrenal crisis.

Levothyroxine increases the basal metabolic rate, which upregulates hepatic enzymes responsible for the metabolism of cortisol. In a patient with limited or absent adrenal reserve (due to ACTH deficiency), this accelerated clearance depletes remaining cortisol levels, triggering an acute crisis.

This establishes the precise biochemical mechanism asked for in the question.

Key Concept

Initiation of thyroid hormone replacement in a patient with undiagnosed central or primary adrenal insufficiency increases hepatic clearance of cortisol, precipitating an acute adrenal crisis.

Question 1525Question →

During a routine occupational health evaluation, a 34-year-old female intensive care unit nurse complains of progressive central adiposity, pronounced muscle weakness when climbing stairs, and easy bruising over the past eight months. She currently works exclusively on nocturnal shifts ( $7:00\text{ PM}$ to $7:00\text{ AM}$ ). Her medical history includes polycystic ovary syndrome, for which she takes a daily combined oral contraceptive pill. Vital signs show a blood pressure of $158/96\text{ mmHg}$ and a pulse of $82/\text{min}$ . Her body mass index is $34\text{ kg/m}^2$ . Physical examination reveals facial plethora, dorsal cervical and supraclavicular fat pad enlargement, and wide, violaceous striae on the lower abdomen. Which of the following is the most appropriate initial laboratory test to screen for this patient's suspected condition?

24-hour urine free cortisol excretion

1-mg overnight dexamethasone suppression test

Late-night salivary cortisol

Serum adrenocorticotropic hormone (ACTH) level

8:00 AM serum cortisol level

Show answer & explanation

Answer: 24-hour urine free cortisol excretion

Answer

The most appropriate test is 24-hour urine free cortisol excretion, as it avoids interference from both the patient's disrupted sleep-wake cycle and her oral contraceptive use.

The correct answer identifies the 24-hour urine free cortisol as the only valid screening test for this patient. While there are three acceptable initial screening tests for Cushing syndrome (24-hour urine free cortisol, late-night salivary cortisol, and 1-mg overnight dexamethasone suppression), the patient's unique history eliminates two of them. Her nocturnal work schedule disrupts her normal circadian rhythm, rendering late-night salivary cortisol highly inaccurate. Furthermore, she takes an oral combined hormonal contraceptive; the estrogen component heavily stimulates hepatic production of cortisol-binding globulin (CBG). Because the 1-mg overnight dexamethasone suppression test measures total serum cortisol rather than free cortisol, the expanded CBG pool holds excess bound cortisol, resulting in a false-positive failure to suppress. The 24-hour urine collection directly measures free, active cortisol and integrates the values over a full day, entirely bypassing the confounding variables of altered CBG and disrupted diurnal variation.

Step-by-Step Solution

Identify the suspected clinical syndrome based on the patient's presentation.

The patient's central adiposity, proximal muscle weakness, easy bruising, wide violaceous striae, and hypertension are classic signs of Cushing syndrome (hypercortisolism).

Recognizing the syndrome dictates the diagnostic algorithm, which begins with biochemical screening for excess cortisol.

Recall the three standard first-line screening tests for Cushing syndrome.

The standard tests are 24-hour urine free cortisol, late-night salivary cortisol, and the 1-mg overnight dexamethasone suppression test.

Any of these three tests can normally be used as an initial screening tool in the general population.

Evaluate patient-specific factors that would invalidate any of the standard screening tests.

The patient is a nocturnal shift worker, which disrupts normal diurnal cortisol variation, invalidating late-night salivary cortisol. She also takes oral contraceptives (estrogen), which increase cortisol-binding globulin (CBG), leading to false positives on the 1-mg dexamethasone suppression test.

Selecting the correct laboratory test requires integrating the patient's pharmacological and social history to avoid false-positive results.

Determine the remaining valid screening test.

The 24-hour urine free cortisol measurement assesses unbound cortisol over an entire day and is unaffected by both CBG fluctuations and diurnal rhythm shifts.

It is the only reliable diagnostic option left for this specific patient profile.

Key Concept

Selecting the appropriate initial screening test for Cushing syndrome requires adjusting for factors that alter cortisol-binding globulin (e.g., oral estrogens) and circadian rhythm (e.g., shift work).

Question 1526Question →

Match each highly specific neurologic clinical vignette to the most appropriate initial or confirmatory diagnostic laboratory test.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Each distinct neurologic presentation matches a highly specific confirmatory laboratory test: NMOSD to AQP4 IgG, anti-NMDA receptor encephalitis to CSF NMDA receptor antibodies, multifocal motor neuropathy to anti-GM1 antibodies, Miller Fisher syndrome to anti-GQ1b antibodies, and Creutzfeldt-Jakob disease to the CSF RT-QuIC assay.

Correctly identifying these diseases requires recognizing highly specific clinical clues (e.g., an adnexal mass pointing to an ovarian teratoma in anti-NMDA receptor encephalitis, or intractable vomiting pointing to area postrema involvement in NMOSD) and knowing their paired autoantibodies or protein assays.

Step-by-Step Solution

Evaluate the patient presenting with optic neuritis, paraparesis, and intractable vomiting.

Identify the presentation as neuromyelitis optica spectrum disorder (NMOSD) featuring area postrema syndrome.

Intractable vomiting originates from area postrema involvement, which is highly specific for NMOSD. The diagnostic test is serum AQP4 IgG.

Analyze the young female patient with acute psychiatric symptoms, autonomic instability, and an adnexal mass.

Diagnose suspected paraneoplastic anti-NMDA receptor encephalitis secondary to an ovarian teratoma.

This classic paraneoplastic syndrome requires diagnostic confirmation via a CSF assay for NMDA receptor antibodies.

Assess the patient with asymmetric, progressive distal upper extremity weakness, absent reflexes, and intact sensation.

Identify multifocal motor neuropathy (MMN).

MMN mimics amyotrophic lateral sclerosis (ALS) but uniquely lacks upper motor neuron signs and sensory deficits, and is diagnostically associated with anti-GM1 antibodies.

Evaluate the patient with the triad of gait ataxia, ophthalmoplegia, and areflexia following a diarrheal illness.

Diagnose Miller Fisher syndrome, a specific variant of Guillain-Barré syndrome.

This specific triad is strongly and uniquely associated with anti-GQ1b antibodies.

Assess the older patient with rapidly progressive cognitive decline, startle myoclonus, and akinetic mutism.

Identify suspected Creutzfeldt-Jakob disease (CJD).

The RT-QuIC assay of the CSF is currently the most sensitive and specific laboratory test for confirming the presence of misfolded prion proteins.

Key Concept

Targeted laboratory evaluation for specific neuro-immunologic and prion diseases

Question 1527Question →

During a routine follow-up visit, a physician evaluates a 62-year-old male with a history of hypertension, type 2 diabetes mellitus, and hyperlipidemia. The patient is currently managed with lisinopril, metformin, and simvastatin. Due to persistently elevated blood pressure readings averaging 158/94 mm Hg, the physician adds oral diltiazem to the regimen. Fourteen days later, the patient presents to the emergency department with profound bilateral thigh and shoulder pain, weakness, and dark urine. Serum laboratory analysis demonstrates a creatine kinase concentration of 12,500 U/L. Which of the following pharmacokinetic alterations of the lipid-lowering agent most likely explains this patient's acute clinical presentation?

Decreased systemic clearance and increased elimination half-life

Increased volume of distribution and prolonged elimination half-life

Decreased oral bioavailability and decreased peak plasma concentration

Displacement from plasma proteins and increased unbound active fraction

Enhanced renal tubular reabsorption and decreased urinary excretion

Show answer & explanation

Answer: Decreased systemic clearance and increased elimination half-life

Answer

Decreased systemic clearance and increased elimination half-life

Simvastatin is a lipid-lowering agent that undergoes extensive metabolism by the hepatic and intestinal CYP3A4 enzyme. Diltiazem, a non-dihydropyridine calcium channel blocker, is a well-known moderate inhibitor of CYP3A4. When diltiazem is added to the patient's regimen, it inhibits the metabolism of simvastatin. In pharmacokinetic terms, this metabolic inhibition directly decreases the systemic clearance (

Cl

) of simvastatin. According to the half-life equation,

t_{1/2} = \frac{0.693 \times V_d}{Cl}

, a decrease in clearance results in a proportional increase in the elimination half-life (

t_{1/2}

), assuming the volume of distribution (

V_d

) remains constant. This leads to drug accumulation, elevated peak plasma concentrations, and an increased risk of dose-dependent adverse effects such as rhabdomyolysis.

Step-by-Step Solution

Identify the patient's new symptoms and laboratory findings

The patient has profound muscle pain, weakness, dark urine, and an elevated creatine kinase (12,500 U/L).

These clinical and laboratory findings are classic for rhabdomyolysis, a known dose-dependent adverse effect of statin toxicity.

Determine the cause of the statin toxicity based on the medication history

The recent addition of diltiazem precipitated the toxicity.

Diltiazem is a known moderate inhibitor of the CYP3A4 enzyme, which is the primary pathway for metabolizing simvastatin.

Apply pharmacokinetic principles to the enzyme inhibition

CYP3A4 inhibition decreases the metabolic breakdown of simvastatin, directly decreasing its systemic clearance.

Because half-life (

t_{1/2}

) is inversely proportional to clearance (

t_{1/2} = \frac{0.693 \times V_d}{Cl}

), a decrease in clearance leads to an increased half-life, resulting in toxic drug accumulation.

Key Concept

Inhibition of hepatic metabolic enzymes (e.g., CYP3A4) decreases the systemic clearance of substrate drugs, leading to an increased elimination half-life and potential dose-dependent toxicity.

Question 1528Question →

A $74$ -year-old man is evaluated in the hospital for persistent shortness of breath. He was admitted three days ago with an acute exacerbation of heart failure with reduced ejection fraction. Over the past $72$ hours, he has been treated with high-dose intravenous furosemide and has had a net fluid loss of $5$ liters. A chest radiograph reveals a moderate right-sided pleural effusion that is unchanged in size from admission. Because of his persistent symptoms and the possibility of a dual pathology, a diagnostic thoracentesis is performed.

Laboratory studies of the serum and pleural fluid are obtained simultaneously:

Test	Serum	Pleural Fluid
Total protein	$6.8$ g/dL	$3.9$ g/dL
Albumin	$4.0$ g/dL	$2.2$ g/dL
Lactate dehydrogenase (LDH)	$160$ U/L	$110$ U/L
pH	Not measured	$7.45$
Nucleated cell count	Not measured	$180$ / $\mu$ L
Differential	Not measured	$85\%$ mononuclear, $15\%$ neutrophils

*(Reference range for serum LDH: $45-200$ U/L)*

Which of the following is the most appropriate interpretation of these laboratory findings?

The fluid is transudative, as established by the elevated serum-to-pleural fluid albumin gradient

The fluid is an exudate resulting from increased pleural capillary permeability

The fluid is transudative because the pleural fluid lactate dehydrogenase is less than two-thirds the upper limit of normal for serum

The fluid is an exudate, as the serum-to-pleural fluid albumin gradient is greater than

1.2

g/dL

The fluid is transudative, as the pleural fluid-to-serum protein ratio is less than

0.6

Show answer & explanation

Answer: The fluid is transudative, as established by the elevated serum-to-pleural fluid albumin gradient

Answer

The fluid is transudative, as established by the elevated serum-to-pleural fluid albumin gradient.

The correct answer identifies that the fluid is a transudate by applying the serum-to-pleural fluid albumin gradient (SPAG). This patient has heart failure and recently underwent massive diuresis (

5

liters). Diuresis causes rapid reabsorption of water from the pleural space, leaving proteins and LDH behind. This concentrates the fluid, causing a transudate to falsely meet Light's criteria for an exudate (a phenomenon known as a pseudo-exudate). In this scenario, the fluid's protein ratio (

0.57

) and LDH ratio (

0.69

) both suggest an exudate. However, calculating the SPAG (Serum albumin

4.0

- Pleural albumin

2.2

1.8

g/dL) reveals a gradient

> 1.2

g/dL, which definitively reclassifies the fluid as a transudate.

Step-by-Step Solution

Calculate Light's criteria ratios for protein and LDH to initially classify the pleural fluid.

Pleural fluid-to-serum (PF/S) protein ratio is

3.9 / 6.8 = 0.57

(exceeds

0.5

). PF/S LDH ratio is

110 / 160 = 0.69

(exceeds

0.6

Light's criteria are the standard first step for differentiating exudates from transudates. Meeting any single criterion categorizes the fluid as an exudate.

Evaluate the fluid classification within the patient's specific clinical context.

The patient has heart failure and underwent aggressive diuresis (

5

L loss), a scenario known to concentrate pleural fluid proteins and LDH.

Water is reabsorbed from the pleural space faster than protein and LDH during diuresis, creating a 'pseudo-exudate' that falsely meets Light's criteria.

Calculate the serum-to-pleural fluid albumin gradient (SPAG).

Serum albumin (

4.0

g/dL) - Pleural fluid albumin (

2.2

g/dL) =

1.8

g/dL.

The SPAG is the indicated secondary test to differentiate a true exudate from a diuretic-induced pseudo-exudate.

Interpret the calculated SPAG to reach a final diagnostic conclusion.

The SPAG is

1.8

g/dL, which is greater than the

1.2

g/dL threshold.

A SPAG

> 1.2

g/dL definitively overrides Light's criteria in this setting, proving the fluid is actually a transudate driven by hydrostatic forces.

Key Concept

In patients with heart failure undergoing aggressive diuresis, pleural fluid can concentrate and falsely meet Light's criteria for an exudate (pseudo-exudate). A serum-to-pleural fluid albumin gradient (SPAG) greater than 1.2 g/dL correctly reclassifies these effusions as transudates.

Estimated Time:2m 0s

Question 1529Question →

Paramedics transport a 58-year-old hypertensive male to the trauma bay after he experienced acute-onset rotational vertigo and collapsed while shoveling snow. He is awake but speaks with a raspy, dysphonic voice and frequently coughs when attempting to swallow his saliva. Vital signs show a blood pressure of 185/105 mmHg, heart rate of 92/min, and respiratory rate of 18/min. Initial cranial nerve assessment reveals right-sided enophthalmos, a drooping right upper eyelid, and a constricted right pupil. His palate elevates asymmetrically, with the uvula pulled toward the left. Which of the following sensory examination deficits is most likely to accompany this patient's clinical presentation?

Impaired pinprick and temperature perception on the left hemiface and the right hemibody

Loss of two-point discrimination and vibratory sense over the left hemibody

Impaired pinprick and temperature perception on the right hemiface and the left hemibody

Global anesthesia affecting the right side of the face and the entire right hemibody

Dissociated sensory loss extending bilaterally across the shoulders and upper extremities

Show answer & explanation

Answer: Impaired pinprick and temperature perception on the right hemiface and the left hemibody

Answer

Impaired pinprick and temperature perception on the right hemiface and the left hemibody

The correct answer describes impaired pinprick and temperature perception on the right hemiface and the left hemibody. The clinical presentation is characteristic of a right lateral medullary (Wallenberg) syndrome, typically due to occlusion of the right posterior inferior cerebellar artery (PICA) or vertebral artery. The right-sided Horner syndrome and the deviation of the uvula to the left (indicating right nucleus ambiguus dysfunction) localize the lesion to the right lateral medulla. In this syndrome, infarction of the right spinal trigeminal nucleus causes loss of pain and temperature sensation on the ipsilateral (right) side of the face. Concurrently, damage to the adjacent right lateral spinothalamic tract causes loss of pain and temperature sensation on the contralateral (left) side of the body.

Step-by-Step Solution

Analyze the cranial nerve deficits to localize the side of the lesion.

Right-sided Horner syndrome (ptosis, miosis, enophthalmos) and uvular deviation to the left (indicating right CN X paralysis) localize the lesion to the right side of the brainstem.

Cranial nerve deficits in brainstem stroke syndromes typically occur ipsilateral to the lesion.

Identify the specific brainstem syndrome based on the constellation of clinical findings.

The combination of vertigo, dysphagia, hoarseness, and Horner syndrome is characteristic of a lateral medullary (Wallenberg) syndrome.

These findings map to the vestibular nuclei, nucleus ambiguus, and descending sympathetic tract located in the lateral medulla.

Determine the expected sensory deficits associated with a right lateral medullary lesion.

Damage to the right spinal trigeminal nucleus causes ipsilateral (right) facial pain/temperature loss, while damage to the right lateral spinothalamic tract causes contralateral (left) body pain/temperature loss.

The spinothalamic tract has already crossed in the spinal cord, while the spinal trigeminal tract represents ipsilateral facial sensation.

Key Concept

Localization of lateral medullary (Wallenberg) syndrome through integration of cranial nerve and sensory physical examination findings

Question 1530Question →

Match the following iron study laboratory profiles with their most likely underlying clinical diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Iron deficiency anemia matches with low ferritin/elevated TIBC; Anemia of chronic disease matches with normal to high ferritin/low TIBC; Hemochromatosis matches with elevated iron/elevated ferritin/low TIBC; Pregnancy matches with normal iron/elevated TIBC/normal ferritin.

Each clinical condition alters iron metabolism uniquely: true iron deficiency depletes stores (low ferritin), chronic disease sequesters iron (high ferritin, low TIBC), hemochromatosis causes vast overload (high ferritin, high iron), and pregnancy strictly increases transport protein synthesis without altering body stores (high TIBC only).

Step-by-Step Solution

Evaluate the serum ferritin level.

Identifies total body iron stores.

Ferritin is the most accurate initial indicator of true iron store status, helping distinguish true deficiency from other states.

Evaluate the total iron-binding capacity (TIBC).

Identifies transferrin levels, which typically move inversely to iron stores or increase in high-estrogen states.

TIBC helps differentiate true deficiency (where it is appropriately elevated) from inflammatory sequestration (where it is low) and helps identify non-anemic alterations in transport proteins.

Key Concept

Interpreting classic iron study profiles to differentiate common causes of altered iron metabolism.

Question 1531Question →

A 24-year-old woman presents to the emergency department with the acute onset of severe, colicky abdominal pain and progressive swelling of her upper lip. The symptoms began 3 hours ago, shortly after a minor dental extraction. She has a history of recurrent, unexplained episodes of severe abdominal pain since adolescence, for which she has undergone multiple non-diagnostic evaluations. She has no history of food or drug allergies. Her only medication is a combined oral contraceptive pill. Vital signs are temperature 37.1°C (98.8°F), heart rate 98/min, blood pressure 118/76 mmHg, and respiratory rate 16/min. Physical examination reveals asymmetric, non-pitting edema of the upper lip and periorbital soft tissue. There is no urticaria, and the lungs are clear to auscultation bilaterally. Laboratory testing reveals a markedly decreased C4 level with a normal C3 level. Which of the following is the most appropriate next step in the management of this patient's acute symptoms?

Administration of an alpha-1, beta-1, and beta-2 adrenergic receptor agonist

Administration of a bradykinin B2 receptor antagonist

Administration of an intravenous histamine H1 receptor antagonist

Computed tomography imaging of the abdomen and pelvis with intravenous contrast

Administration of systemic corticosteroids and transition to a daily angiotensin-converting enzyme inhibitor

Show answer & explanation

Answer: Administration of a bradykinin B2 receptor antagonist

Answer

The most appropriate next step is the administration of a bradykinin B2 receptor antagonist.

The correct answer involves administering a bradykinin B2 receptor antagonist. The patient's presentation of non-pitting facial edema without urticaria, recurrent unexplained abdominal pain, and symptom onset after dental trauma is characteristic of hereditary angioedema (HAE). The laboratory findings of a markedly decreased C4 level with a normal C3 level confirm the diagnosis. HAE is caused by a deficiency or dysfunction of the C1 esterase inhibitor, leading to unregulated activation of kallikrein and overproduction of bradykinin. Bradykinin acts on B2 receptors to cause potent vasodilation and increased vascular permeability. Acute attacks must be treated with targeted therapies such as a bradykinin B2 receptor antagonist (e.g., icatibant), a kallikrein inhibitor (e.g., ecallantide), or purified C1-INH concentrate.

Step-by-Step Solution

Analyze the patient's clinical presentation and history.

The combination of non-pitting facial edema without urticaria, recurrent unexplained abdominal pain, and onset following dental trauma strongly suggests hereditary angioedema (HAE).

HAE classically presents with episodes of cutaneous angioedema, intense abdominal pain (due to bowel wall edema), and can be triggered by stress or tissue trauma (e.g., dental procedures).

Interpret the specific laboratory findings.

A markedly decreased C4 level with a normal C3 level confirms the diagnosis of a C1 esterase inhibitor (C1-INH) deficiency.

C1-INH deficiency leads to uninhibited autoactivation of C1, which continuously consumes C4. C3 remains normal because the classical pathway C3 convertase is unstable without adequate immune complex formation.

Identify the underlying pathophysiologic mediator and select targeted therapy.

HAE is mediated by excess bradykinin. The most appropriate acute targeted therapy is a bradykinin B2 receptor antagonist (icatibant), a kallikrein inhibitor, or C1-INH concentrate.

Standard allergic therapies (epinephrine, antihistamines, corticosteroids) target IgE- and histamine-mediated pathways and are entirely ineffective in bradykinin-mediated angioedema.

Key Concept

Hereditary angioedema is a bradykinin-mediated condition due to C1 esterase inhibitor deficiency, characterized by normal C3 and low C4 levels, and treated acutely with bradykinin B2 receptor antagonists, kallikrein inhibitors, or C1-INH replacement.

Question 1532Question →

Match each classic abdominal physical examination finding with its corresponding underlying anatomical or pathophysiological mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Courvoisier sign corresponds to gradual malignant biliary obstruction; Kehr sign corresponds to phrenic nerve-mediated diaphragmatic irritation; Cruveilhier-Baumgarten murmur corresponds to portosystemic shunting via the falciform ligament; Grey Turner sign corresponds to retroperitoneal hemorrhage tracking along the flank fascia.

Each physical examination finding is a direct result of specific anatomical relationships and pathophysiologic processes. Courvoisier sign occurs because a non-inflamed gallbladder can distend under the pressure of a distal malignant obstruction, unlike a fibrosed gallbladder in gallstone disease. Kehr sign is a classic example of referred pain where diaphragmatic irritation is interpreted by the brain as somatic pain in the C3-C5 distribution. The Cruveilhier-Baumgarten murmur results from turbulent flow in portosystemic collaterals, specifically the umbilical vein within the falciform ligament. Grey Turner sign represents the physical manifestation of retroperitoneal hemorrhage migrating to the subcutaneous tissues of the flank.

Step-by-Step Solution

Analyze Courvoisier sign

Matched to gradual malignant obstruction of the biliary tree distal to the cystic duct.

The sign describes a distended, non-tender gallbladder. This occurs in chronic distal obstruction (usually malignant), without the fibrotic scarring seen in chronic inflammatory cholecystitis.

Analyze Kehr sign

Matched to diaphragmatic irritation with referred pain mediated by the C3-C5 nerve roots.

Blood or exudate in the subdiaphragmatic space irritates the phrenic nerve, referring pain to the corresponding C3-C5 sensory dermatomes at the shoulder.

Analyze Cruveilhier-Baumgarten murmur

Matched to portosystemic collateralization involving a recanalized vein within the falciform ligament.

Portal hypertension forces blood into the systemic circulation via the umbilical vein remnant, which is structurally located within the falciform ligament.

Analyze Grey Turner sign

Matched to extravasation of hemorrhagic exudate from the retroperitoneum along the transversalis and quadratus lumborum fascia.

Hemorrhagic fluid from retroperitoneal organs (such as the pancreas) tracks laterally to the flanks, presenting superficially as ecchymosis.

Key Concept

Anatomical and pathophysiological basis of classic abdominal physical examination signs.

Question 1533Question →

A 45-year-old man weighing $80 \text{ kg}$ is admitted to the hospital with a severe skin and soft tissue infection. The physician decides to initiate therapy with a novel oral antimicrobial agent. To ensure immediate therapeutic effect, a loading dose is required. The target peak plasma concentration for this medication is $15 \text{ mg/L}$ . The drug has a known volume of distribution of $0.6 \text{ L/kg}$ and an oral bioavailability of $75\%$ .

What is the required oral loading dose in mg to achieve the desired peak plasma concentration?

Show answer & explanation

Answer: 960

Answer

960

The required oral loading dose is found by first determining the total volume of distribution (

0.6 \text{ L/kg} \times 80 \text{ kg} = 48 \text{ L}

). Next, this volume is multiplied by the target peak concentration (

15 \text{ mg/L}

) to find the required systemic drug amount (

720 \text{ mg}

). Finally, dividing by the oral bioavailability fraction (

0.75

) accounts for incomplete absorption and first-pass metabolism, yielding a final loading dose of

960 \text{ mg}

Step-by-Step Solution

Calculate the total volume of distribution (

V_d

) for the patient.

V_d = 0.6 \text{ L/kg} \times 80 \text{ kg} = 48 \text{ L}

The volume of distribution is provided per kilogram of body weight, so it must be scaled to the patient's actual weight.

Calculate the total amount of drug required in the systemic circulation.

\text{Amount} = 48 \text{ L} \times 15 \text{ mg/L} = 720 \text{ mg}

The total amount of drug needed in the body is the product of the target peak concentration and the total volume of distribution.

Adjust for the drug's oral bioavailability (

F

) to find the required oral loading dose.

\text{Oral Loading Dose} = \frac{720 \text{ mg}}{0.75} = 960 \text{ mg}

Since only

75\%

of the orally administered dose reaches the systemic circulation, the calculated IV equivalent dose must be divided by the bioavailability fraction.

Key Concept

The oral loading dose is calculated using the formula:

\text{Loading Dose} = \frac{V_d \times \text{Target Concentration}}{F}

, taking care to calculate the total

V_d

based on patient weight.

Alternative Method

The calculation can be performed in a single combined formula:

\text{Loading Dose} = \frac{V_d \times \text{Weight} \times \text{Target Concentration}}{F} = \frac{0.6 \times 80 \times 15}{0.75} = 960 \text{ mg}

Estimated Time:1m 30s

Question 1534Question →

A 65-year-old man is brought to the emergency department by his daughter due to progressive confusion, lethargy, and anorexia over the past week. He has a history of hypertension, type 2 diabetes mellitus, and major depressive disorder. Four weeks ago, fluoxetine was added to his regimen for worsening depression. His other medications include lisinopril and metformin. Vital signs are temperature 37.0°C (98.6°F), blood pressure 128/78 mm Hg, pulse 76/min, and respirations 14/min. Physical examination reveals moist mucous membranes, normal skin turgor, clear lungs, and no jugular venous distention or peripheral edema. Neurologic examination shows disorientation to time and place but no focal deficits.

Laboratory results are as follows:

Laboratory Test	Result	Reference Range
Serum sodium	118 mEq/L	136-145 mEq/L
Serum potassium	4.1 mEq/L	3.5-5.0 mEq/L
Blood urea nitrogen (BUN)	8 mg/dL	7-18 mg/dL
Serum creatinine	0.7 mg/dL	0.6-1.2 mg/dL
Serum glucose	115 mg/dL	70-110 mg/dL
Serum osmolality	252 mOsm/kg H₂O	275-295 mOsm/kg H₂O
Urine osmolality	450 mOsm/kg H₂O	50-1200 mOsm/kg H₂O
Urine sodium	48 mEq/L	20-40 mEq/L

Thyroid-stimulating hormone (TSH) and morning serum cortisol levels are within normal limits.

Based on the clinical presentation and laboratory results, which of the following is the most likely underlying cause of this patient's condition?

Adverse effect of fluoxetine

Osmotic fluid shifts from hyperglycemia

Volume depletion from inadequate oral intake

Psychogenic primary polydipsia

Adverse effect of lisinopril

Show answer & explanation

Answer: Adverse effect of fluoxetine

Answer

The most likely underlying cause of this patient's condition is an adverse effect of fluoxetine, which has triggered the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

The correct answer identifies an adverse effect of fluoxetine. This patient's laboratory workup shows hypotonic hyponatremia (serum sodium

118 \text{ mEq/L}

, serum osmolality

252 \text{ mOsm/kg H}_2\text{O}

). In the setting of clinical euvolemia, the diagnostic next step is evaluating urine studies. A normal physiological response to hypotonicity is complete suppression of antidiuretic hormone (ADH), which would result in maximally dilute urine (

< 100 \text{ mOsm/kg H}_2\text{O}

). This patient's inappropriately concentrated urine (

450 \text{ mOsm/kg H}_2\text{O}

) signifies excess ADH activity. Coupled with an elevated urine sodium (

48 \text{ mEq/L}

) reflecting appropriate sodium handling by the kidneys and normal thyroid/adrenal tests, this profile definitively points to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are notorious for causing SIADH, particularly in elderly patients.

Step-by-Step Solution

Evaluate the serum osmolality to classify the hyponatremia.

The patient's measured serum osmolality is

252 \text{ mOsm/kg H}_2\text{O}

, confirming true (hypotonic) hyponatremia.

This step distinguishes true hypotonic hyponatremia from pseudohyponatremia (isotonic) and translocational hyponatremia (hypertonic, such as in severe hyperglycemia).

Assess the patient's clinical and biochemical volume status.

The physical examination shows moist mucous membranes and no edema, while the blood urea nitrogen (BUN) is appropriately low-normal (

8 \text{ mg/dL}

). Both indicate a euvolemic state.

Categorizing volume status as hypovolemic, euvolemic, or hypervolemic narrows the differential diagnosis considerably.

Analyze urine osmolality and urine sodium concentrations.

The urine is inappropriately concentrated (

450 \text{ mOsm/kg H}_2\text{O}

) in the face of hypotonicity, and the urine sodium is elevated (

48 \text{ mEq/L}

A urine osmolality

> 100 \text{ mOsm/kg H}_2\text{O}

indicates failure to suppress ADH. A urine sodium

> 40 \text{ mEq/L}

confirms appropriate renal sodium excretion in a volume-expanded (but clinically euvolemic) state, distinguishing SIADH from volume-depleted states.

Synthesize the laboratory data with the patient's history to identify the etiology.

The laboratory pattern is perfectly consistent with SIADH. The recent initiation of fluoxetine, an SSRI known to cause SIADH in older adults, is the definitive trigger.

Connecting the diagnostic pattern of SIADH to the medication list is crucial for determining the underlying cause and guiding management.

Key Concept

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) typically presents as euvolemic, hypotonic hyponatremia with inappropriately concentrated urine (typically

> 100 \text{ mOsm/kg H}_2\text{O}

) and elevated urine sodium (

> 40 \text{ mEq/L}

). Selective serotonin reuptake inhibitors (SSRIs) are a classic pharmacological trigger for SIADH, particularly in older adults.

Question 1535Question →

A 68-year-old man is brought to the emergency department by his family due to confusion and lethargy that has progressively worsened over the last week. He has a history of small cell lung cancer, for which he is currently receiving chemotherapy. His temperature is 37.0°C (98.6°F), blood pressure is 124/78 mm Hg, and pulse is 76/min. Physical examination shows moist mucous membranes, normal skin turgor, and no jugular venous distention or peripheral edema.

Laboratory test results are as follows:
Serum sodium: 120 mEq/L (Reference: 136-145 mEq/L)
Serum potassium: 4.0 mEq/L (Reference: 3.5-5.0 mEq/L)
Blood urea nitrogen: 8 mg/dL (Reference: 7-18 mg/dL)
Serum creatinine: 0.7 mg/dL (Reference: 0.6-1.2 mg/dL)
Serum osmolality: 255 mOsm/kg $H_2O$ (Reference: 275-295 mOsm/kg $H_2O$ )
Urine osmolality: 550 mOsm/kg $H_2O$
Urine sodium: 60 mEq/L

Based on the clinical and laboratory findings, which of the following is the most likely diagnosis?

Syndrome of inappropriate antidiuretic hormone secretion

Primary polydipsia

Congestive heart failure

Primary adrenal insufficiency

Central diabetes insipidus

Show answer & explanation

Answer: Syndrome of inappropriate antidiuretic hormone secretion

Answer

Syndrome of inappropriate antidiuretic hormone secretion

The correct answer is the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This patient presents with hypotonic hyponatremia (serum sodium less than 135 mEq/L and serum osmolality less than 275 mOsm/kg

H_2O

). In the evaluation of hypotonic hyponatremia, assessing the patient's volume status is paramount. This patient is euvolemic based on the physical examination. The elevated urine osmolality indicates that the kidneys are concentrating the urine despite low serum osmolality, which is an inappropriate physiological response. Furthermore, the elevated urine sodium (greater than 40 mEq/L) reflects euvolemia and normal sodium handling by the kidneys in the setting of water retention. These findings, combined with his history of small cell lung cancer (a common cause of ectopic antidiuretic hormone production), make SIADH the most likely diagnosis.

Step-by-Step Solution

Evaluate the patient's volume status based on the physical examination.

The physical examination shows moist mucous membranes, normal skin turgor, and no edema or jugular venous distention, indicating a euvolemic state.

Determining volume status (euvolemic, hypovolemic, or hypervolemic) is the crucial first step in evaluating the underlying cause of hyponatremia.

Analyze the serum and urine laboratory values in the context of the volume status.

The patient has hyponatremia with low serum osmolality (hypotonic), elevated urine osmolality (inappropriately concentrated), and high urine sodium (greater than 40 mEq/L).

These lab values in a euvolemic patient confirm inappropriate antidiuretic hormone activity rather than an appropriate physiological response to volume depletion.

Synthesize the laboratory findings with the clinical history to establish the most likely diagnosis.

The laboratory profile indicates the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which is a well-known paraneoplastic complication of small cell lung cancer.

Small cell lung cancer frequently secretes ectopic antidiuretic hormone, leading to water retention and dilutional hyponatremia.

Key Concept

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) presents as euvolemic hypotonic hyponatremia with inappropriately concentrated urine (elevated urine osmolality) and elevated urine sodium.

Question 1536Question →

A 72-year-old man is brought to the emergency department by his daughter after experiencing a syncopal episode at home. For the past two weeks, he has noted worsening fatigue and lightheadedness. His medical history is significant for open-angle glaucoma, benign prostatic hyperplasia, and osteoarthritis. His current oral medications include tamsulosin and acetaminophen. He explicitly denies starting any new oral medications or making changes to his current regimen. On presentation, his blood pressure is 105/60 mmHg, and his pulse is 42/min. An electrocardiogram reveals profound sinus bradycardia without ischemic changes. Which of the following is the most appropriate next step in evaluating this patient's medical history?

Inquire about the use of medicated eye drops

Inquire about recent use of over-the-counter cold and sinus preparations

Ask about regular consumption of grapefruit juice

Elicit a history of recent outdoor activities or tick exposures

Inquire about a family history of sudden cardiac death

Show answer & explanation

Answer: Inquire about the use of medicated eye drops

Answer

The most appropriate next step is to explicitly ask the patient if he uses medicated eye drops, as topical beta-blockers for glaucoma can cause systemic bradycardia.

The correct response addresses the need to clarify non-oral medication use. This patient has open-angle glaucoma and presents with symptomatic sinus bradycardia. Timolol, a non-selective beta-blocker, is frequently prescribed as an ophthalmic solution for glaucoma. Because these medications drain into the nasal mucosa and bypass hepatic first-pass metabolism, systemic absorption can lead to profound beta-blockade, causing bradycardia and syncope. Patients routinely fail to report eye drops, inhalers, or topical creams when asked broadly about their 'medications,' making direct inquiry a critical step in a thorough medical history evaluation.

Step-by-Step Solution

Analyze the patient's acute presentation and vital signs.

The patient has symptomatic sinus bradycardia (pulse 42/min) leading to syncope and hypotension.

Identifying the primary physiological derangement (bradycardia) limits the differential diagnosis.

Correlate the vital signs with the patient's past medical history.

The patient has a history of open-angle glaucoma.

Chronic medical conditions often directly link to current presentations through disease progression or iatrogenic medication effects.

Evaluate the medication history for missing elements.

The patient denied new 'oral' medications, but patients commonly do not consider eye drops to be medications.

Ophthalmic beta-blockers (e.g., timolol) can undergo systemic absorption via the nasolacrimal duct, bypass hepatic first-pass metabolism, and cause significant systemic beta-blockade.

Key Concept

Patients frequently omit topical, inhaled, or ophthalmic preparations when providing a medication history. Direct and specific inquiry is required when suspecting adverse effects from these routes, such as systemic beta-blockade from glaucoma drops.

Question 1537Question →

Match each patient's clinical presentation to the most appropriate targeted diagnostic laboratory test.

Click a left item, then click its matching right item

Show answer & explanation

Answer

1) Symmetric MCP arthritis matches Anti-cyclic citrullinated peptide antibodies. 2) Dry eyes and dry mouth matches Anti-Ro/SSA and anti-La/SSB antibodies. 3) Recurrent miscarriages and DVT matches Lupus anticoagulant and anticardiolipin antibodies. 4) Thickened skin on fingers, Raynaud phenomenon, and heartburn matches Anti-centromere antibodies.

Each clinical vignette provides a classic presentation of a specific rheumatologic or autoimmune condition that requires targeted laboratory evaluation to confirm the diagnosis. Rheumatoid arthritis is confirmed with highly specific anti-CCP antibodies. Sjögren syndrome is characterized by sicca symptoms and is associated with anti-Ro/SSA and anti-La/SSB antibodies. Antiphospholipid syndrome presents with thrombosis and pregnancy loss, requiring lupus anticoagulant and anticardiolipin antibody testing. Limited cutaneous systemic sclerosis (CREST syndrome) presents with Raynaud phenomenon, sclerodactyly, and esophageal dysmotility, and is strongly associated with anti-centromere antibodies.

Step-by-Step Solution

Analyze the first clinical vignette to identify the most likely underlying diagnosis.

The patient with symmetric MCP joint swelling and prolonged morning stiffness has a classic presentation of rheumatoid arthritis (RA).

Recognizing the pathognomonic clinical features of RA allows for the selection of its most specific diagnostic laboratory marker.

Determine the most specific initial laboratory test for the suspected diagnosis of RA.

Anti-cyclic citrullinated peptide (anti-CCP) antibodies are selected for the first vignette.

While rheumatoid factor is sensitive, anti-CCP is highly specific for RA and is the most appropriate targeted test to confirm the diagnosis.

Analyze the second vignette (sicca symptoms and parotid enlargement) to identify the diagnosis and required test.

The clinical picture is highly suggestive of Sjögren syndrome, warranting testing for Anti-Ro/SSA and anti-La/SSB antibodies.

Identifying the autoimmune exocrinopathy directs testing toward its specific diagnostic autoantibodies.

Evaluate the third vignette (thrombosis, mid-trimester miscarriages) to determine the necessary lab workup.

The presentation is characteristic of antiphospholipid syndrome (APS), requiring Lupus anticoagulant and anticardiolipin antibody testing.

Recognizing the combination of unprovoked venous thrombosis and pregnancy morbidity is critical for guiding the serologic evaluation of APS.

Analyze the fourth vignette (sclerodactyly, Raynaud phenomenon, GERD).

The patient has limited cutaneous systemic sclerosis (CREST syndrome), which requires testing for Anti-centromere antibodies.

Identifying this specific scleroderma variant guides the selection of the correct diagnostic and prognostic autoantibody.

Key Concept

Targeted autoantibody testing in rheumatologic and autoimmune diseases

Question 1538Question →

A 56-year-old woman is brought to the emergency department by her husband due to progressive confusion, worsening hand tremors, and an unsteady gait over the past week. She has a history of bipolar I disorder, which has been well controlled on a stable regimen of lithium carbonate for the past five years. Her medical history also includes essential hypertension, hyperlipidemia, and severe osteoarthritis. Vital signs are within normal limits. Physical examination reveals coarse resting tremors, generalized hyperreflexia, and truncal ataxia. A basic metabolic panel is notable for a serum creatinine of 1.4 mg/dL, elevated from a baseline of 0.9 mg/dL three months ago. Her serum lithium level is 2.2 mEq/L (therapeutic range: 0.6-1.2 mEq/L). Which of the following recent changes in the patient's history are the most likely precipitants of her acute clinical syndrome? (Select two that apply)

Select all that apply

Commencing daily use of over-the-counter naproxen for osteoarthritis flares

Filling a new prescription for lisinopril to optimize blood pressure management

Adding amlodipine to her regimen as a replacement antihypertensive agent

Discontinuing her lipid-lowering medication due to mildly elevated serum aminotransferases

Sustaining an embedded tick bite during a recent hiking trip to an endemic area

Show answer & explanation

Answer: Commencing daily use of over-the-counter naproxen for osteoarthritis flares; Filling a new prescription for lisinopril to optimize blood pressure management

Answer

The critical historical elements are the recent initiation of naproxen and the new prescription for lisinopril, as both drugs drastically reduce renal lithium clearance.

The patient presents with classic signs of acute lithium toxicity accompanied by an elevated serum lithium level and acute kidney injury. Because lithium is almost entirely excreted by the kidneys and is reabsorbed in the proximal tubule alongside sodium, any factor that decreases glomerular filtration rate or enhances proximal sodium reabsorption will increase lithium levels. Nonsteroidal anti-inflammatory drugs (such as naproxen) and angiotensin-converting enzyme inhibitors (such as lisinopril) alter renal blood flow and enhance proximal tubular reabsorption of lithium. Eliciting a history of recent initiation of either of these agents is critical, as they drastically reduce lithium clearance and precipitate toxicity.

Step-by-Step Solution

Analyze the clinical presentation and laboratory results.

The patient exhibits classic signs of lithium toxicity (coarse tremors, ataxia, hyperreflexia, confusion) confirmed by a toxic serum level of 2.2 mEq/L and an acute rise in serum creatinine.

Establishing the definitive diagnosis (acute lithium toxicity with acute kidney injury) focuses the medical history evaluation on identifying recent precipitating factors.

Evaluate the mechanism of lithium clearance.

Lithium is cleared almost exclusively by the kidneys, heavily relying on glomerular filtration and proximal tubular reabsorption alongside sodium.

Understanding the pharmacokinetic pathways helps identify which xenobiotics or physiological changes would alter its clearance.

Identify interacting medications from the provided history options.

NSAIDs (naproxen) and ACE inhibitors (lisinopril) are identified as agents that alter renal hemodynamics, increasing proximal reabsorption of lithium and causing toxicity.

Differentiating these interacting agents from non-interacting agents (like amlodipine) is essential for accurate diagnosis and management.

Key Concept

Pharmacokinetic evaluation of the medical history in patients taking lithium, specifically identifying concurrent medications that alter renal hemodynamics (NSAIDs, ACE inhibitors, thiazide diuretics) and precipitate acute toxicity.

Estimated Time:2m 0s

Question 1539Question →

A 65-year-old man is evaluated in the hospital on postoperative day 3 following an open abdominal hernia repair. He reports new-onset right-sided chest pain and shortness of breath that began earlier this morning. His temperature is 37.6°C (99.7°F), blood pressure is 132/84 mmHg, pulse is 108/min, and respiratory rate is 22/min. Pulse oximetry shows 91% on room air. Physical examination of the chest reveals dullness to percussion, decreased breath sounds, and absent tactile fremitus over the right lower lung field. Palpation of the neck demonstrates that the trachea is deviated toward the right side. Which of the following is the most likely diagnosis?

Atelectasis

Pleural effusion

Lobar pneumonia

Pulmonary embolism

Pneumothorax

Show answer & explanation

Answer: Atelectasis

Answer

Atelectasis

The patient's physical examination findings are classic for atelectasis, a common postoperative complication often caused by a retained mucous plug. When a large bronchus is obstructed, the distal air is resorbed, leading to alveolar collapse (volume loss). This volume loss manifests as dullness to percussion, absent tactile fremitus, and decreased or absent breath sounds over the affected area. Because the lung volume on the right side has significantly decreased, the negative intrathoracic pressure pulls the compliant mediastinal structures, including the trachea, toward the affected side (ipsilateral deviation).

Step-by-Step Solution

Analyze the patient's clinical presentation and vital signs.

The patient is postoperative with acute-onset hypoxia, tachycardia, tachypnea, and right-sided chest pain.

Establishing the clinical context helps narrow the differential diagnosis for acute dyspnea in a hospital setting.

Interpret the pulmonary auscultation and percussion findings.

Dullness to percussion, decreased breath sounds, and absent tactile fremitus indicate that air in the right lower lung has been replaced by fluid or solid tissue, or the lung has collapsed.

These findings differentiate an air-filled process (like pneumothorax) from a fluid-filled or collapsed state.

Evaluate the palpation of the trachea.

The trachea is deviated to the right (ipsilateral side), indicating severe volume loss on the affected side pulling the mediastinum toward it.

Tracheal deviation is the critical differentiating factor between atelectasis (pulls toward), pleural effusion (pushes away), and lobar pneumonia (remains midline).

Key Concept

Physical examination differentiation of pulmonary pathologies based on percussion, fremitus, and tracheal deviation.

Question 1540Question →

A 52-year-old man comes to the clinic for progressive abdominal swelling, generalized fatigue, and bilateral lower extremity edema over the past 4 months. His medical history is significant for Hodgkin lymphoma, which was treated with chemotherapy and mantle field radiation 25 years ago. His pulse is 95/min, and blood pressure is 110/70 mm Hg. Physical examination reveals jugular venous distention that becomes paradoxically more pronounced upon deep inspiration. Abdominal examination shows shifting dullness and a palpable, non-pulsatile liver edge 4 cm below the right costal margin. Bilateral 2+ pitting edema is present up to the knees. Which of the following additional cardiovascular physical examination findings is most likely to be present in this patient?

A sharp, high-pitched early diastolic sound occurring shortly after the second heart sound

An inspiratory decrease in systolic arterial pressure of greater than 10 mm Hg

A harsh, holosystolic murmur at the left lower sternal border that increases with inspiration

A low-pitched, mid-diastolic rumbling murmur with a preceding opening snap

A palpable systolic thrill over the right second intercostal space with a delayed carotid upstroke

Show answer & explanation

Answer: A sharp, high-pitched early diastolic sound occurring shortly after the second heart sound

Answer

A sharp, high-pitched early diastolic sound occurring shortly after the second heart sound

The correct answer is a sharp, high-pitched early diastolic sound occurring shortly after the second heart sound. This patient's presentation of progressive right-sided heart failure (edema, hepatomegaly, ascites) and a history of mantle field radiation points strongly to constrictive pericarditis. The physical examination confirms this with the presence of Kussmaul sign (a paradoxical rise in jugular venous pressure during inspiration). In constrictive pericarditis, the fibrotic, rigid pericardium restricts ventricular expansion. When the ventricles fill rapidly in early diastole, they abruptly hit the physical limit of the thickened pericardium, creating a sharp, high-pitched early diastolic sound known as a pericardial knock.

Step-by-Step Solution

Analyze the patient's history and presenting symptoms.

The patient has a history of mediastinal (mantle field) radiation and presents with signs of severe right-sided heart failure (peripheral edema, hepatomegaly, ascites).

Prior radiation therapy is a major risk factor for delayed cardiac complications, most notably constrictive pericarditis, restrictive cardiomyopathy, and valvular disease.

Evaluate the specific physical examination findings provided in the stem.

The patient exhibits a paradoxical rise in jugular venous pressure during inspiration, known as Kussmaul sign.

Normally, JVP falls during inspiration due to decreased intrathoracic pressure. Kussmaul sign indicates impaired right ventricular filling, highly specific for constrictive pericarditis or restrictive cardiomyopathy.

Correlate the suspected diagnosis with expected auscultatory findings.

Constrictive pericarditis is classically associated with a pericardial knock.

A pericardial knock is a high-pitched, early diastolic sound caused by the sudden cessation of rapid ventricular filling due to a rigid, thickened pericardium. It occurs slightly earlier in diastole than an S3 gallop.

Key Concept

Patients with prior mediastinal radiation presenting with right heart failure and Kussmaul sign likely have constrictive pericarditis, classically associated with an early diastolic pericardial knock.

PreviousPage 77 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution